Topical application of synthetic melanin promotes tissue repair
Authors:
- Dauren BiyashevDBDauren Biyashev
- Zofia E. SiwickaZSZofia E. Siwicka
- Ummiye V. OnayUOUmmiye V. Onay
- Michael DemczukMDMichael Demczuk
- Dan XuDXDan Xu
- Madison K. ErnstMEMadison K. Ernst
- Spencer T. EvansSESpencer T. Evans
- Cuong V. NguyenCNCuong V. Nguyen
- Florencia A. SonFSFlorencia A. Son
- Navjit K. PaulNPNavjit K. Paul
- Naneki C. McCallumNMNaneki C. McCallum
- Omar K. FarhaOFOmar K. Farha
Open Access
- 2 November 2023
- journal article
- research article
- Published by Springer Nature in npj Regenerative Medicine
- Vol. 8 (1) , 1-14
Abstract
In acute skin injury, healing is impaired by the excessive release of reactive oxygen species (ROS). Melanin, an efficient scavenger of radical species in the skin, performs a key role in ROS scavenging in response to UV radiation and is upregulated in response to toxic insult. In a chemical injury model in mice, we demonstrate that the topical application of synthetic melanin particles (SMPs) significantly decreases edema, reduces eschar detachment time, and increases the rate of wound area reduction compared to vehicle controls. Furthermore, these results were replicated in a UV-injury model. Immune array analysis shows downregulated gene expression in apoptotic and inflammatory signaling pathways consistent with histological reduction in apoptosis. Mechanistically, synthetic melanin intervention increases superoxide dismutase (SOD) activity, decreases Mmp9 expression, and suppresses ERK1/2 phosphorylation. Furthermore, we observed that the application of SMPs caused increased populations of anti-inflammatory immune cells to accumulate in the skin, mirroring their decrease from splenic populations. To enhance antioxidant capacity, an engineered biomimetic High Surface Area SMP was deployed, exhibiting increased wound healing efficiency. Finally, in human skin explants, SMP intervention significantly decreased the damage caused by chemical injury. Therefore, SMPs are promising and effective candidates as topical therapies for accelerated wound healing, including via pathways validated in human skin.Keywords
Funding Information
- United States Department of Defense | United States Air Force | AFMC | Air Force Office of Scientific Research (FA 9550-18-1-0142)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-19-1-0010)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-19-1-0010)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR079795)
This publication has 60 references indexed in Scilit:
- Hydrogen Peroxide in Inflammation: Messenger, Guide, and AssassinAdvances in Hematology, 2012
- Krüppel-like factor 4 regulates macrophage polarizationJournal of Clinical Investigation, 2011
- Bioinspired Polymerization of Dopamine to Generate Melanin-Like Nanoparticles Having an Excellent Free-Radical-Scavenging PropertyBiomacromolecules, 2011
- Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?Journal of Signal Transduction, 2011
- Hollow Carved Single-Crystal Mesoporous Silica Templated by Mesomorphous Polyelectrolyte−Surfactant ComplexesChemistry of Materials, 2010
- Mechanisms Mediating the Vesicant Actions of Sulfur Mustard after Cutaneous ExposureToxicological Sciences, 2009
- Physicochemical Properties and Antioxidant Activities of Luteolin-Phospholipid ComplexMolecules, 2009
- The Protective Role of Melanin Against UV Damage in Human Skin†Photochemistry and Photobiology, 2007
- Preparation and characterization of eugenol‐grafted chitosan hydrogels and their antioxidant activitiesJournal of Applied Polymer Science, 2006
- Superoxide Dismutase 1 Knock-down Induces Senescence in Human FibroblastsJournal of Biological Chemistry, 2003